We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$996K
Cap. Flow
+$5.81M
Cap. Flow %
4.86%
Top 10 Hldgs %
38.86%
Holding
79
New
17
Increased
26
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$3.24M
2
ALK icon
Alaska Air
ALK
+$2.41M
3
RPRX icon
Royalty Pharma
RPRX
+$2.19M
4
EG icon
Everest Group
EG
+$1.97M
5
HPQ icon
HP
HPQ
+$1.75M

Top Sells

Rank Stock Value
1
TGB
Trekor Metals
TGB
+$9.62M
2
FOLD
Amicus Therapeutics
FOLD
+$5.27M
3
PLPC icon
Preformed Line Products
PLPC
+$5.17M
4
CGAU
Centerra Gold
CGAU
+$2.87M
5
KDP icon
Keurig Dr Pepper
KDP
+$2.24M

Sector Composition

Rank Sector Weight
1 Healthcare 38.22%
2 Financials 12.92%
3 Technology 11.1%
4 Industrials 10%
5 Consumer Staples 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHDN icon
51
Churchill Downs
CHDN
$6.27B
$898K 0.75%
+10,000
New +$950K
CTSO icon
52
Cytosorbents Corp
CTSO
$21.1M
$836K 0.7%
1,476,500
– –
EEFT icon
53
Euronet Worldwide
EEFT
$2.62B
$830K 0.69%
12,500
– –
HRTX icon
54
Heron Therapeutics
HRTX
$62M
$800K 0.67%
1,000,000
+250,000
+33% +$290K
NWL icon
55
Newell Brands
NWL
$2.63B
$686K 0.57%
200,000
– –
AVNW icon
56
Aviat Networks
AVNW
$256M
$678K 0.57%
30,000
+10,000
+50% +$239K
SVC
57
Service Properties Trust
SVC
$1.02B
$678K 0.57%
100,000
+20,000
+25% +$208K
ASRT
58
DELISTED
Assertio
ASRT
$667K 0.56%
35,000
-15,000
-30% -$185K
GUTS icon
59
Fractyl Health
GUTS
$105M
$641K 0.54%
1,400,000
+600,000
+75% +$553K
GNLX icon
60
Genelux
GNLX
$120M
$605K 0.51%
+250,000
New +$682K
OSTX
61
OS Therapies Inc
OSTX
$76.2M
$564K 0.47%
400,000
– –
SWK icon
62
Stanley Black & Decker
SWK
$14.8B
$533K 0.45%
+7,500
New +$602K
KDP icon
63
Keurig Dr Pepper
KDP
$43.8B
$527K 0.44%
20,000
-80,000
-80% -$2.24M
WGO icon
64
Winnebago Industries
WGO
$865M
$465K 0.39%
+15,000
New +$625K
CWH icon
65
Camping World
CWH
$417M
$410K 0.34%
+60,000
New +$618K
NVNO
66
enVVeno Medical
NVNO
$7.47M
$362K 0.3%
35,714
– –
LTRN icon
67
Lantern Pharma
LTRN
$26.5M
$343K 0.29%
250,000
+25,000
+11% +$69.9K
CGTX icon
68
Cognition Therapeutics
CGTX
$97M
$304K 0.25%
400,000
+200,000
+100% +$233K
ELTX icon
69
Elicio Therapeutics
ELTX
$74.6M
$267K 0.22%
25,000
– –
BCDA icon
70
BioCardia
BCDA
$17.4M
$157K 0.13%
130,000
– –
CRIS icon
71
Curis
CRIS
$3.61M
$82.1K 0.07%
7,500
-8,750
-54% -$163K
CGAU
72
Centerra Gold
CGAU
$4.59B
– –
-200,000
Closed -$2.87M
CMPX icon
73
Compass Therapeutics
CMPX
$432M
– –
-100,000
Closed -$537K
CRGY icon
74
Crescent Energy
CRGY
$4.47B
– –
-175,000
Closed -$1.47M
FOLD
75
DELISTED
Amicus Therapeutics
FOLD
– –
-370,000
Closed -$5.27M
1 2
3
4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q1 2026 Portfolio in Review

As of Q1 2026, CM Management held 79 positions worth $120M, up 0.84% from $119M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CM Management deployed $5.81M of net new capital in Q1 2026, opening 17 new positions and adding to 26 existing holdings. Its largest new stake was Charles River Laboratories: 17,500 shares worth $3.02M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $2.24M trimmed.

  • CM Management's largest Q1 2026 buy was Charles River Laboratories: 17,500 shares worth $3.02M.
  • CM Management added most to Royalty Pharma in Q1 2026, an estimated $2.19M increase.
  • CM Management's biggest Q1 2026 reduction was Keurig Dr Pepper, cutting an estimated $2.24M.
  • CM Management fully exited Trekor Metals in Q1 2026, selling an estimated $9.62M.
  • CM Management's ten largest holdings make up 39% of its $120M portfolio in Q1 2026.
  • CM Management opened 17 new positions and closed 8 in Q1 2026.
  • CM Management's portfolio value rose 0.84% quarter-over-quarter to $120M.

Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.